Haijun ma, PhD

Exelixis Inc.

Haijun is currently Head of Biostatistics at Exelixis Inc., an oncology-focused biotech company innovating cancer treatments for life. She is passionate about drug development and clinical trials with 17+ years of industry experience in big pharma, small and mid-sized biotechs. She is a seasoned statistical leader with experiences in Phase I/II/III/IV clinical trials, post marketing safety studies and real-world data (RWD). She has extensive scientific collaborations with experts across industry, academia and regulatory agencies and has published peer reviewed manuscripts and book chapters in the areas including clinical trials, RWD, pharmacoepidemiology, benefit risk assessment, meta-analysis, survival analysis and Bayesian statistics. She holds a PhD in Biostatistics from The University of Minnesota Twin Cities and MS degrees from in statistics from The Iowa State University.